Bio-Path Holdings Inc (NASDAQ: BPTH) today publicized that the United States Patent and Trademark Office has approved a new Copyright connecting to the company’s BP1003 suite. The original liposome-incorporated oligodeoxynucleotide inhibitor in contradiction of Sign Transduction and Activator of Transcription-3 (STAT3). The Copyright (U.S. Patent No. 11,041,153) is designated “P-Ethoxy […]